首页>
外国专利>
NITROXY GROUP-CONTAINING BENZYLAMINE DERIVATIVES AND THEIR USE FOR TREATING CARDIOVASCULAR DISEASES, AS WELL AS INCREASED INTRA-OCULAR PRESSURE,
NITROXY GROUP-CONTAINING BENZYLAMINE DERIVATIVES AND THEIR USE FOR TREATING CARDIOVASCULAR DISEASES, AS WELL AS INCREASED INTRA-OCULAR PRESSURE,
展开▼
机译:含氮基的苄胺衍生物及其在治疗心血管疾病以及增加眼内压中的用途,
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to compounds of the general formula (I) and salts thereof.;(7);Wherein A1 is C1-15Alkylene, C5-7Of cycloalkylene or di-C1-4Alkylene-C5-7Cycloalkane; R1 is hydrogen, C1-7Alkyl or C3-8/RTI R2 is hydrogen, C1-7Alkyl, C3-8Or R 1 and R 2 are taken together with the nitrogen atom to form unsubstituted or substituted 5 RTI-, 6-or 7-membered heterocycle; A2 is C1-15Alkylene, C5-7Of cycloalkylene or di-C1-4Alkylene-C5-7Cycloalkane; Y is R3, NH2, NH-R4 or S-R5, the-substituted picolide group is C1-4Alkyl, C1-4Alkoxy and hydroxy, the substituted piperidine group is substituted with one or two identical or different substituents selected from the group consisting of C1-4Alkyl, C1-4Alkoxy and hydroxy, the substituted piperazine group is substituted by one or more of the same or different substituents selected from the group consisting of C1-4May be substituted at the 2-, 3-, 5-, or 6-position, and the 4-position may be substituted with C1-4Alkyl, C1-4Alkoxycarbonyl, C1-4Phenyl substituted with R6, R7 and R8, phenyl-substituted with R6, R7 and R8 in the phenyl group1-4-alkyl, benzoyl, picolinoyl, nicotinoyl, isonicotinoyl, optionally halogen or C RTI ID = 0.0 1-4-alkyl substituted benzhydryl and the R4 group, the substituted morpholin group is substituted with one or two identical or different C1-4Substituted homofiperazines are substituted with an alkyl group of C1-4-alkyl, C1-4-alkoxycarbonyl, C1-4-alkylcarbonyl, phenyl substituted with R6, R7 and R8, phenyl-C-substituted with R6, R7 and R8 in the phenyl group1-4-benzoyl substituted in the alkyl and phenyl group with R6, R7 and R8; R3 is furyl, naphthyl, tetrahydronaphthyl,-O-Al-ONO2Substituted phenyl or phenyl substituted by R6, R7 and R8; R4 is C1-7-alkyl /RTI or substituted-CH2-CH (OH)-(CH2O)p-Ar; R5 is R6, R7 and R8 substituted phenyl, R6, R7 and R8 are substituted phenyl-C1-4-alkyl, optionally halogen or C RTI ID = 0.0 1-4Alkyl-substituted benzhydryl, dibenzo-C5-7-cycloalkanyl, dibenzocycloheptenyl or benzo-pyrido-C5-7-cycloalkanyl; R6 is hydrogen, C1-4-alkyl, C1-4-alkoxy, C1-4-alkoxy, C1-4-alkylcarbonyl, halogenamino, mono-or di-(C1-4Alkyl) amino or nitro; R7 is hydrogen, C1-4-alkyl, C1-4-alkoxy, halogen or nitro; R 8 is hydrogen or trifluoromethyl; P is an integer of 0 or 1; Ar is a hydrocarbon ring system of fully or partially unsaturated monocyclic (containing 5 to 6 ring atoms) or bicyclic (containing 9 to 10 ring atoms) wherein 1, 2 or 3 carbon atoms contain nitrogen (N ), Oxygen (O) or sulfur (S) may be inserted, and C1-4-alkyl, C1-4-alkoxy, C1-4-alkylthio, C1-4Alkoxy-C1-4-alkyl, C1-4-alkoxy-C1-4-alkoxy, C3-4-alkenyl, C3-4-alkenyloxy, C3-8-cycloalkyl, C5-10-cycloalkylalkoxyalkyl, C RTI ID = 0.0 1-4-alkylcarbonyl, C1-4-alkylcarbonylamino, carbamoyl, carbamoyl-C1-4-alkyl, halogen, hydroxy, oxonitro, cyan C1-4-alkylsulfonamido, amino, mono-or di-(C1-4-alkyl) amino, ureido, mono-or di-(C1-4-alkyl) ureido, mono-or di-(C3-8-cycloalkyl) ureido, trifluoromethyl, fully or partially fluoro substituted C1-4-alkoxy, C1-4-alkoxycarbonyl, tetrahydrofurfuryloxy or morpholino, or a pharmaceutically acceptable salt thereof. These compounds are useful in the treatment of cardiovascular diseases and elevated intraocular pressure.
展开▼